DC-based immunotherapy for relapsed high grade glioma: clinical update of cohort A, B, C and D from the cohort comparison trial HGG-immuno-2003

Authors :: De Vleeschouwer, S.
Ardon, H.
Fieuws, S.
Van Calenbergh, F.
Goffin, J.
Van Loon, J.
Van Gool, S.
Source :: 60. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit den Benelux-Ländern und Bulgarien; 20090524-20090527; Münster; DOCMI.09-01 /20090520/
Publication Year :: 2009
Publisher :: German Medical Science GMS Publishing House; Düsseldorf, 2009.
Abstract: Objective: The prognosis of patients with high-grade glioma (HGG) is dismal. We investigate the therapeutic role of vaccination with mature dendritic cells (DC) loaded with tumor lysates derived from resected tumor at the time of a relapse. Methods: Dendritis cells were injected intradermally according[for full text, please go to the a.m. URL]<br />60. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit den Benelux-Ländern und Bulgarien

Language :: English
Database :: OpenAIRE
Journal :: 60. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit den Benelux-Ländern und Bulgarien; 20090524-20090527; Münster; DOCMI.09-01 /20090520/
Accession number :: edsair.doi.dedup.....66236ff1c74a795e4f7776515eb6e90d
Full Text :: https://doi.org/10.3205/09dgnc230

Full Text Access

Tools